Monogram Orthopaedics Common Stock Revenue

MGRM Stock   2.08  0.11  5.58%   
Monogram Orthopaedics Common fundamentals help investors to digest information that contributes to Monogram Orthopaedics' financial success or failures. It also enables traders to predict the movement of Monogram Stock. The fundamental analysis module provides a way to measure Monogram Orthopaedics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Monogram Orthopaedics stock.
Last ReportedProjected for Next Year
Total Revenue365 K356.7 K
At this time, Monogram Orthopaedics' Stock Based Compensation To Revenue is very stable compared to the past year. As of the 26th of November 2024, Revenue Per Share is likely to grow to 0.02, while Current Deferred Revenue is likely to drop 0.95.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Monogram Orthopaedics Common Company Revenue Analysis

Monogram Orthopaedics' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Revenue

 = 

Money Received

-

Discounts and Returns

More About Revenue | All Equity Analysis

Current Monogram Orthopaedics Revenue

    
  365 K  
Most of Monogram Orthopaedics' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Monogram Orthopaedics Common is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Historical and Projected quarterly revenue of Monogram

Projected quarterly revenue analysis of Monogram Orthopaedics provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Monogram Orthopaedics match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Monogram Orthopaedics' stock price.

Monogram Revenue Driver Correlations

Understanding the fundamental principles of building solid financial models for Monogram Orthopaedics is extremely important. It helps to project a fair market value of Monogram Stock properly, considering its historical fundamentals such as Revenue. Since Monogram Orthopaedics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Monogram Orthopaedics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Monogram Orthopaedics' interrelated accounts and indicators.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Competition

Monogram Current Deferred Revenue

Current Deferred Revenue

0.95

At this time, Monogram Orthopaedics' Current Deferred Revenue is very stable compared to the past year.
Based on the latest financial disclosure, Monogram Orthopaedics Common reported 365 K of revenue. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 99.99% lower than that of the Health Care industry. The revenue for all United States stocks is 100.0% higher than that of the company.

Monogram Revenue Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Monogram Orthopaedics' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Monogram Orthopaedics could also be used in its relative valuation, which is a method of valuing Monogram Orthopaedics by comparing valuation metrics of similar companies.
Monogram Orthopaedics is currently under evaluation in revenue category among its peers.

Monogram Orthopaedics Current Valuation Drivers

We derive many important indicators used in calculating different scores of Monogram Orthopaedics from analyzing Monogram Orthopaedics' financial statements. These drivers represent accounts that assess Monogram Orthopaedics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Monogram Orthopaedics' important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Enterprise Value343.5M338.3M338.4M333.9M64.0M60.8M

Monogram Fundamentals

About Monogram Orthopaedics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Monogram Orthopaedics Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Monogram Orthopaedics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Monogram Orthopaedics Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Monogram Orthopaedics is a strong investment it is important to analyze Monogram Orthopaedics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Monogram Orthopaedics' future performance. For an informed investment choice regarding Monogram Stock, refer to the following important reports:
Check out Monogram Orthopaedics Piotroski F Score and Monogram Orthopaedics Altman Z Score analysis.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Monogram Orthopaedics. If investors know Monogram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Monogram Orthopaedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.47)
Revenue Per Share
0.012
Return On Assets
(0.61)
Return On Equity
(1.22)
The market value of Monogram Orthopaedics is measured differently than its book value, which is the value of Monogram that is recorded on the company's balance sheet. Investors also form their own opinion of Monogram Orthopaedics' value that differs from its market value or its book value, called intrinsic value, which is Monogram Orthopaedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Monogram Orthopaedics' market value can be influenced by many factors that don't directly affect Monogram Orthopaedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Monogram Orthopaedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Monogram Orthopaedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monogram Orthopaedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.